Dietmar Berger (Sanofi)

End­ing a gru­el­ing 10-year drought, Sanofi fi­nal­ly wins an OK for an in-house can­cer drug

Sanofi has snagged an FDA ap­proval for a top drug in its pipeline, end­ing a 10-year drought of home-grown can­cer drug ap­provals as the new …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.